Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association, discusses pharmacists’ role in diabetes and CKD care at ASN Kidney Week 2026.
|Videos|July 14, 2015
Important Differences in Treatment Guidelines for Dyslipidemia
Karen J. McConnell, PharmD, FCCP, BCPS, describes differences in treatment for dyslipidemia.
Advertisement
Karen J. McConnell, PharmD, FCCP, BCPS, clinical pharmacy specialist in cardiology at the Kaiser Permanente of Colorado and associate professor at the Skaggs School of Pharmacy (University of Colorado), describes differences in treatment for dyslipidemia.
This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.
Advertisement
Related to this article
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
In a Korean cohort of 1861 patients with nondialysis CKD, intake below 0.6 g/kg/d was linked to more kidney failure and higher all-cause mortality.
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Over Half of RSV-Related Deaths in Hospitalized Adults Occur After Discharge
2
Caitlin McClain, Peggy Lillis Foundation Board Member, Shares Her Experience With C difficile
3
Community Pharmacists Guide Patients New to Glucose Monitoring
4
Early Nirmatrelvir/Ritonavir Linked to Lower Long COVID Risk in High-Risk Outpatients
5